Reply to Kalil et al., “Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?”
Author(s) -
George Sakoulas,
Matthew Geriak,
Fadi Haddad,
Warren E. Rose,
Kerry L. LaPlante,
Marcus Zervos,
Ravina Kullar,
Victor Nizet
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01347-19
Subject(s) - daptomycin , medicine , bacteremia , staphylococcus aureus , staphylococcal infections , antibiotics , intensive care medicine , microbiology and biotechnology , vancomycin , bacteria , biology , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom